Evaluation of scientific advertisements of pharmaceutical products as per UCPMP Guidelines

Preeti Pati, Virendra Siddharam Ligade, Pradeep Manohar Muragundi

Research output: Contribution to journalReview article

Abstract

Background: Uniform Code for Pharmaceutical Marketing Practices (UCPMP), issued by the Department of Pharmaceuticals, introduced in India after several years of deliberations. The UCPMP is to be voluntarily adopted and implemented by pharmaceutical companies. The main aim of study was to evaluate the scientific advertisements of pharmaceutical products as per uniform code of pharmaceutical marketing practices (UCPMP) draft guidelines Methodology: Printed copies of the journals in Manipal University Health Sciences Library were scrutinised to identify Indian journals containing advertisements. All the selected journals published during the time period from Jan, 2012 to Dec, 2014 were further scrutinised to identify advertisements for evaluation. All the selected advertisements were evaluated for its content as per the UCPMP guidelines and the observations were recorded in the data collection sheet prepared for the study. The collected data was coded and entered into SPSS software. The results are presented in the form of descriptive statistic. Results: Some parameters such as claims-safe (85.9%), no side effect (98.9%), no toxic hazards (99.2%), word new (96.3%), brand name of competitors (99.6%), name and address of company (93.8%), method of administration (71%), method of use (88%), additional information on request (65.5%) and name and photo of healthcare professionals (97.9%) for full ads almost adhere to guidelines. Whereas some parameter such as claims without references (56.8%), date of advertisement (25.3%), adverse reaction, warnings, precaution for use and contraindications (50.2%), recommended dose (55.6%) for full ads do not follow guidelines. Conclusion: The present study has clearly shown the discrepancies in the usage of references for the substantiation of claims made and recommended dose.

Original languageEnglish
Pages (from-to)391-394
Number of pages4
JournalJournal of Young Pharmacists
Volume9
Issue number3
DOIs
Publication statusPublished - 01-07-2017

Fingerprint

Marketing
Practice Guidelines
Pharmaceutical Preparations
Names
Guidelines
Medical Libraries
Poisons
India
Software
Delivery of Health Care

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{1e955ffd75c0487a986f3ddd080829b0,
title = "Evaluation of scientific advertisements of pharmaceutical products as per UCPMP Guidelines",
abstract = "Background: Uniform Code for Pharmaceutical Marketing Practices (UCPMP), issued by the Department of Pharmaceuticals, introduced in India after several years of deliberations. The UCPMP is to be voluntarily adopted and implemented by pharmaceutical companies. The main aim of study was to evaluate the scientific advertisements of pharmaceutical products as per uniform code of pharmaceutical marketing practices (UCPMP) draft guidelines Methodology: Printed copies of the journals in Manipal University Health Sciences Library were scrutinised to identify Indian journals containing advertisements. All the selected journals published during the time period from Jan, 2012 to Dec, 2014 were further scrutinised to identify advertisements for evaluation. All the selected advertisements were evaluated for its content as per the UCPMP guidelines and the observations were recorded in the data collection sheet prepared for the study. The collected data was coded and entered into SPSS software. The results are presented in the form of descriptive statistic. Results: Some parameters such as claims-safe (85.9{\%}), no side effect (98.9{\%}), no toxic hazards (99.2{\%}), word new (96.3{\%}), brand name of competitors (99.6{\%}), name and address of company (93.8{\%}), method of administration (71{\%}), method of use (88{\%}), additional information on request (65.5{\%}) and name and photo of healthcare professionals (97.9{\%}) for full ads almost adhere to guidelines. Whereas some parameter such as claims without references (56.8{\%}), date of advertisement (25.3{\%}), adverse reaction, warnings, precaution for use and contraindications (50.2{\%}), recommended dose (55.6{\%}) for full ads do not follow guidelines. Conclusion: The present study has clearly shown the discrepancies in the usage of references for the substantiation of claims made and recommended dose.",
author = "Preeti Pati and {Siddharam Ligade}, Virendra and Muragundi, {Pradeep Manohar}",
year = "2017",
month = "7",
day = "1",
doi = "10.5530/jyp.2017.9.78",
language = "English",
volume = "9",
pages = "391--394",
journal = "Journal of Young Pharmacists",
issn = "0975-1483",
publisher = "E-Flow Medknow Publications",
number = "3",

}

Evaluation of scientific advertisements of pharmaceutical products as per UCPMP Guidelines. / Pati, Preeti; Siddharam Ligade, Virendra; Muragundi, Pradeep Manohar.

In: Journal of Young Pharmacists, Vol. 9, No. 3, 01.07.2017, p. 391-394.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Evaluation of scientific advertisements of pharmaceutical products as per UCPMP Guidelines

AU - Pati, Preeti

AU - Siddharam Ligade, Virendra

AU - Muragundi, Pradeep Manohar

PY - 2017/7/1

Y1 - 2017/7/1

N2 - Background: Uniform Code for Pharmaceutical Marketing Practices (UCPMP), issued by the Department of Pharmaceuticals, introduced in India after several years of deliberations. The UCPMP is to be voluntarily adopted and implemented by pharmaceutical companies. The main aim of study was to evaluate the scientific advertisements of pharmaceutical products as per uniform code of pharmaceutical marketing practices (UCPMP) draft guidelines Methodology: Printed copies of the journals in Manipal University Health Sciences Library were scrutinised to identify Indian journals containing advertisements. All the selected journals published during the time period from Jan, 2012 to Dec, 2014 were further scrutinised to identify advertisements for evaluation. All the selected advertisements were evaluated for its content as per the UCPMP guidelines and the observations were recorded in the data collection sheet prepared for the study. The collected data was coded and entered into SPSS software. The results are presented in the form of descriptive statistic. Results: Some parameters such as claims-safe (85.9%), no side effect (98.9%), no toxic hazards (99.2%), word new (96.3%), brand name of competitors (99.6%), name and address of company (93.8%), method of administration (71%), method of use (88%), additional information on request (65.5%) and name and photo of healthcare professionals (97.9%) for full ads almost adhere to guidelines. Whereas some parameter such as claims without references (56.8%), date of advertisement (25.3%), adverse reaction, warnings, precaution for use and contraindications (50.2%), recommended dose (55.6%) for full ads do not follow guidelines. Conclusion: The present study has clearly shown the discrepancies in the usage of references for the substantiation of claims made and recommended dose.

AB - Background: Uniform Code for Pharmaceutical Marketing Practices (UCPMP), issued by the Department of Pharmaceuticals, introduced in India after several years of deliberations. The UCPMP is to be voluntarily adopted and implemented by pharmaceutical companies. The main aim of study was to evaluate the scientific advertisements of pharmaceutical products as per uniform code of pharmaceutical marketing practices (UCPMP) draft guidelines Methodology: Printed copies of the journals in Manipal University Health Sciences Library were scrutinised to identify Indian journals containing advertisements. All the selected journals published during the time period from Jan, 2012 to Dec, 2014 were further scrutinised to identify advertisements for evaluation. All the selected advertisements were evaluated for its content as per the UCPMP guidelines and the observations were recorded in the data collection sheet prepared for the study. The collected data was coded and entered into SPSS software. The results are presented in the form of descriptive statistic. Results: Some parameters such as claims-safe (85.9%), no side effect (98.9%), no toxic hazards (99.2%), word new (96.3%), brand name of competitors (99.6%), name and address of company (93.8%), method of administration (71%), method of use (88%), additional information on request (65.5%) and name and photo of healthcare professionals (97.9%) for full ads almost adhere to guidelines. Whereas some parameter such as claims without references (56.8%), date of advertisement (25.3%), adverse reaction, warnings, precaution for use and contraindications (50.2%), recommended dose (55.6%) for full ads do not follow guidelines. Conclusion: The present study has clearly shown the discrepancies in the usage of references for the substantiation of claims made and recommended dose.

UR - http://www.scopus.com/inward/record.url?scp=85027075146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027075146&partnerID=8YFLogxK

U2 - 10.5530/jyp.2017.9.78

DO - 10.5530/jyp.2017.9.78

M3 - Review article

VL - 9

SP - 391

EP - 394

JO - Journal of Young Pharmacists

JF - Journal of Young Pharmacists

SN - 0975-1483

IS - 3

ER -